Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Adenocarcinoma
Interventions: DRUG: Epirubicin with Cyclophosphamide, followed by a Taxane|DRUG: Epirubicin with a Taxane
Sponsor: Pfizer